Carola Ledderose Selected Research

Carola Ledderose Research Topics

Disease

12	Sepsis (Septicemia) 01/2023 - 09/2008
8	Inflammation (Inflammations) 01/2021 - 09/2008
6	Neoplasms (Cancer) 04/2023 - 01/2011
4	Heart Failure 03/2014 - 12/2010
3	Infections 10/2023 - 12/2018
3	Hypoxia (Hypoxemia) 01/2020 - 03/2014
2	Bacterial Infections (Bacterial Infection) 01/2023 - 01/2023
2	Wounds and Injuries (Trauma) 01/2020 - 09/2015
2	Septic Shock (Toxic Shock Syndrome) 01/2016 - 05/2009
1	Disease Progression 10/2023
1	Human Influenza (Influenza) 10/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2023
1	Critical Illness (Critically Ill) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Reperfusion Injury 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Ischemia 01/2020
1	Hypothermia 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Leukemia 01/2016
1	Starvation 03/2014
1	Fibrosis (Cirrhosis) 11/2013
1	Glucocorticoid Receptor Deficiency 10/2012
1	Glioblastoma (Glioblastoma Multiforme) 02/2011
1	Glioma (Gliomas) 02/2011
1	Persistent Infection 01/2011
1	Malnutrition (Nutritional Deficiencies) 01/2011
1	Lung Diseases (Lung Disease) 01/2011
1	Obesity 01/2011
1	Cachexia 01/2011
1	Weight Gain 01/2011

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphate (ATP)IBA 10/2023 - 01/2016
5	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 05/2009
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2016 - 09/2008
2	MicroRNAs (MicroRNA)IBA 10/2012 - 02/2012
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 02/2012 - 05/2009
2	GhrelinIBA 01/2011 - 12/2010
2	LipopolysaccharidesIBA 05/2009 - 09/2008
1	Purinergic P2X7 ReceptorsIBA 04/2023
1	Purinergic P2X ReceptorsIBA 04/2023
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2023
1	EndotoxinsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	triphosphoric acid (triphosphate)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Diphosphates (Pyrophosphates)IBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Purinergic P2Y1 ReceptorsIBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2018
1	InflammasomesIBA 12/2018
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 12/2016
1	AntigensIBA 02/2016
1	Small Interfering RNA (siRNA)IBA 03/2014
1	AdipokinesIBA 03/2014
1	AdiponectinIBA 03/2014
1	Adiponectin ReceptorsIBA 03/2014
1	Galectins (Galectin)IBA 11/2013
1	LectinsIBA 11/2013
1	Galectin 3 (LGALS3)IBA 11/2013
1	Protein Isoforms (Isoforms)IBA 10/2012
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2012
1	SteroidsIBA 10/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2012
1	Alkylating AgentsIBA 02/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2011
1	Messenger RNA (mRNA)IBA 02/2011
1	Temozolomide (Temodar)FDA LinkGeneric 02/2011
1	MethyltransferasesIBA 02/2011
1	Growth Hormone (Somatotropin)IBA 01/2011
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009
1	LigandsIBA 05/2009

Therapy/Procedure

1	Critical Care (Surgical Intensive Care) 01/2020
1	Induced Hypothermia 01/2020
1	Resuscitation 09/2015
1	Therapeutics 10/2012
1	Radiotherapy 02/2011
1	Drug Therapy (Chemotherapy) 01/2011